Compare Elevance Health Inc. Common Stock (ELV) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Elevance Health Inc. Common Stock vs IDEXX Laboratories, Inc. — how do they compare? Elevance Health Inc. Common Stock trades at $416.74 (market cap $86.95B), while IDEXX Laboratories, Inc. trades at $519.64 (market cap $40.43B). The key difference: Elevance Health Inc. Common Stock is far larger — about 2.2× IDEXX Laboratories, Inc.'s market cap, and Elevance Health Inc. Common Stock pays a 1.72% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| ELV | IDXX | |
|---|---|---|
Market Cap | $86.95B | $40.43B |
Volume | 782,706 | 692,164 |
Sector | Health | Health |
52-Week High | $426.79 | $766.68 |
52-Week Low | $280.74 | $504.70 |
Enterprise Value | $107.76B | $41.32B |
Dividend Yield | 1.72% | — |
Typical Hold Time | — | 46 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IDEXX Laboratories (IDXX) trades at $519.87, up 2.61% on the day, with a bearish technical signal from moving averages but strong fundamentals including a 25.03% net income margin and consistent earnings beats. Revenue grew to $4.3B in 2025, and the company recently acquired CoVetAI to enhance veterinary workflow intelligence, signaling strategic expansion.
The stock's outlook is supported by robust profitability and analyst consensus, but faces headwinds from technical weakness and potential market volatility. With a $665 price target implying significant upside, the primary risks include competitive pressures and execution of growth initiatives amid economic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Elevance Health Inc. Common Stock
Elevance Health provides health plans and healthcare services. Its offerings include medical, behavioral health, pharmacy, dental, vision, and complex-care solutions, including through the Carelon business.
Read more on ELV →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
